On Oct 25,2018, Duopharma Biotech had acquired a 5.8% stake in SCM Lifescience for 5.5 billion won or RM20.24mil.
KUALA LUMPUR: Duopharma Biotech Bhd
’s investee company, SCM Lifescience Co Ltd has been listed on Kosdaq, which is a trading board of Korea Exchange in South Korea.
SCM Lifescience specialises in stem cell therapeutics with proprietary platform technology in the field of high-purity isolation and cultivation of mesenchymal stem cells and is currently focusing on autoimmune diseases.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
